(2E)-3-(dimethylamino)-1-(3-thienyl)prop-2-en-1-one, 250mg

Nalpha-(5-Fluoro-2,4-dinitrophenyl)-L-leucinamide [HPLC Labeling Reagent for e.e. Determination]>98.0%(HPLC)100mg

2-Methyltetradecan-1-ol, 95%, 100mg

Bromuro de indio (III), anhidro 99,99+% 25 g

Tetramethyl 2,2',2'',2'''-(((ethane-1,2-diylbis(oxy))bis(2,1-phenylene))bis(azanetriyl))tetraacetate, 95.0%, 25g

2-Methyl-5-(4-nitrobenzoyl)pyridine, 97.0%, 1g

2-Methylbenzene-1,4-diol, 95.0%, 25g

methyl 5-amino-1-phenyl-1H-pyrazole-4-carboxylate, 95.0%, 1g

4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)piperidine hydrochloride, 98%, 250mg

OBACUNONE, 95%, 25mg

2,7-Diazaspiro[4.4]nonan-1-one hydrochloride, 95.0%, 1g

Bis(tetrabutylammonium) Dihydrogen Bis(isothiocyanato)bis(2,2'-bipyridyl-4,4'-dicarboxylato)ruthenium(II)>75.0%(HPLC)100mg

Dibutyl 2-methylenesuccinate, (stabilized with HQ), 98% (stabilized with HQ), 25g